Literature DB >> 23478309

Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Stephen W Scheff1, Douglas A Price, Frederick A Schmitt, Kelly N Roberts, Milos D Ikonomovic, Elliott J Mufson.   

Abstract

Amnestic mild cognitive impairment (aMCI) is considered to be one of the early stages in the progression from no cognitive impairment (NCI) to Alzheimer's disease (AD). Individuals with aMCI have increased levels of AD-type neuropathology in multiple regions of the neocortex and hippocampus and demonstrate a loss of synaptic connectivity. Recent neuroimaging studies have reported increased levels of 11C-PiB (Pittsburgh, compound B) in regions of the neocortex including the precuneus region of the medial parietal lobe. This cortical region has been implicated in episodic memory, which is disrupted early in the progression of AD. In this study, unbiased stereology coupled with electron microscopy was used to quantify total synaptic numbers in lamina 3 of the precuneus from short postmortem autopsy tissue harvested from subjects who died at different cognitive stages during the progression of AD. Individuals with aMCI did not reveal a statistically significant decline in total synapses compared to the NCI cohort while the AD group did show a modest but significant decline. Synaptic numbers failed to correlate with several different cognitive tasks including the Mini-Mental State Examination scores and episodic memory scores. Although levels of [3H]PiB binding were elevated in both the aMCI and AD groups, it did not strongly correlate with synaptic counts. These results support the idea that despite increased amyloid load, the precuneus region does not show early changes in synaptic decline during the progression of AD.

Entities:  

Mesh:

Year:  2013        PMID: 23478309      PMCID: PMC4000262          DOI: 10.3233/JAD-122353

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  86 in total

1.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

2.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

3.  Hippocampal drebrin loss in mild cognitive impairment.

Authors:  Scott E Counts; Bin He; Muhammad Nadeem; Joanne Wuu; Stephen W Scheff; Elliott J Mufson
Journal:  Neurodegener Dis       Date:  2012-02-04       Impact factor: 2.977

4.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

5.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 6.  Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.

Authors:  Anders M Fjell; Kristine B Walhovd
Journal:  Mol Neurobiol       Date:  2011-12-27       Impact factor: 5.590

7.  Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.

Authors:  Duygu Tosun; Norbert Schuff; Chester A Mathis; William Jagust; Michael W Weiner
Journal:  Brain       Date:  2011-03-22       Impact factor: 13.501

8.  Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.

Authors:  Audrey Perrotin; Elizabeth C Mormino; Cindee M Madison; Amynta O Hayenga; William J Jagust
Journal:  Arch Neurol       Date:  2012-02

9.  Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

Authors:  D Kogure; H Matsuda; T Ohnishi; T Asada; M Uno; T Kunihiro; S Nakano; M Takasaki
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

Review 10.  Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Authors:  Ann D Cohen; Gil D Rabinovici; Chester A Mathis; William J Jagust; William E Klunk; Milos D Ikonomovic
Journal:  Adv Pharmacol       Date:  2012
View more
  29 in total

1.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

Review 2.  Biomarkers for the Early Detection and Progression of Alzheimer's Disease.

Authors:  Scott E Counts; Milos D Ikonomovic; Natosha Mercado; Irving E Vega; Elliott J Mufson
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 3.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

4.  Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Mubeen A Ansari; Kelly N Roberts; Frederick A Schmitt; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Hippocampal endosomal, lysosomal, and autophagic dysregulation in mild cognitive impairment: correlation with aβ and tau pathology.

Authors:  Sylvia E Perez; Bin He; Muhammad Nadeem; Joanne Wuu; Stephen D Ginsberg; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Neuropathol Exp Neurol       Date:  2015-04       Impact factor: 3.685

Review 6.  Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

Authors:  Milos D Ikonomovic; Zhiping Mi; Eric E Abrahamson
Journal:  Ageing Res Rev       Date:  2016-11-06       Impact factor: 10.895

7.  Spared behavioral repetition effects in Alzheimer's disease linked to an altered neural mechanism at posterior cortex.

Authors:  Lucas S Broster; Juan Li; Benjamin Wagner; Charles D Smith; Gregory A Jicha; Frederick A Schmitt; Nancy Munro; Ryan H Haney; Yang Jiang
Journal:  J Clin Exp Neuropsychol       Date:  2018-02-20       Impact factor: 2.475

8.  Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.

Authors:  Sylvia E Perez; Bin He; Muhammad Nadeem; Joanne Wuu; Stephen W Scheff; Eric E Abrahamson; Milos D Ikonomovic; Elliott J Mufson
Journal:  Biol Psychiatry       Date:  2014-01-11       Impact factor: 13.382

Review 9.  Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.

Authors:  Cassia R Overk; Eliezer Masliah
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

10.  Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease.

Authors:  Kathrin Koch; Nicholas E Myers; Jens Göttler; Lorenzo Pasquini; Timo Grimmer; Stefan Förster; Andrei Manoliu; Julia Neitzel; Alexander Kurz; Hans Förstl; Valentin Riedl; Afra M Wohlschläger; Alexander Drzezga; Christian Sorg
Journal:  Cereb Cortex       Date:  2014-07-04       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.